[Previous Months][Date Index][Thread Index][Join - Register][Login]
[Message Prev][Message Next][Thread Prev][Thread Next]
[IP] text of attachments previously emailed
Here is the text from the attachments I emailed previously (regarding islet tx
in Memphis), for those who could not open the documents.
The inclusion criteria include men and women with Type 1 diabetes for greater
than five (5) years, between the ages of 18-55, with a BMI of 28 or less, with
difficulty controlling blood glucose resulting in metabolic instability. C-
peptide must be <0.48 ng/ml, and urine creatinine clearance must be >50
cc/minute with microalbuminuria <300 ug/min.
Exclusion criteria include anyone with untreated diabetic retinopathy,
hyperlipidemia uncontrolled by medication, uncorrectable cardiovascular
disease, active infection, liver disease, gallstones, previous transplant
recipients, malignancy, or anyone currently smoking or using recreational
To conduct this assessment, we will need the following laboratory tests done
and results faxed or mailed to our office at:
Transplant Clinical Pharmacotherapy Research Institute
920 Madison Avenue, Suite 520
Memphis, TN 38104
These laboratory tests include:
Serum creatinine, BUN, glucose, liver function profile, Hemoglobin A-1C,
complete blood count, platelets, PSA, HBsAg, HBsAb, HBcAb, hepatitis C, and HIV
serology, UA, and stool guiac X3
The other results we need are a recent ophthalmic evaluation determining
diabetic retinopathy status.
Please contact the Islet Transplant Coordinator at 1-901-448-2633 or e-mail at
email @ redacted if you have any additional questions.
We appreciate your inquiry about our islet transplant program. At this time,
we are screening interested islet candidates in a two-step manner. Interested
individuals are asked to complete the attached health history survey and
forward requested laboratory tests to the Transplant Team as part of the
initial screening process. Once we receive this information, we will review
each islet candidates record, determine insurance coverage, and contact them
regarding eligibility for transplantation and arrange a pre-transplant
As you may be aware, the transplant program in Memphis was started in 1970 and
has successfully completed over 1500 kidney, 500 liver, and 300 pancreas and
kidney-pancreas transplants with world-class results. We have had a special
interest in the area of diabetes, diabetic complications, and in treatment of
diabetes by transplantation. Although excellent results have been obtained with
whole organ pancreas transplantation at our institution, we have continued to
investigate methods for improving human islet transplantation. Recently,
researchers at Edmonton reported that human islet transplantation resulted in
euglycemia and normalization of glycosylated hemoglobin (HgBA1C) in 15 Type I
diabetes without concomitant kidney failure. A steroid-free anti-rejection
medical protocol was used.
The islet transplant group in Memphis is currently one of five Islet Cell
Resource centers funded by National Institutes of Health for pancreas
procurement and islet isolation. Our program has recently secured FDA approval
for our clinical islet transplant protocol and is in the process of screening
applicants for transplantation. We intend to use the Edmonton protocol for our
next 10 islet transplants and have developed some exciting monitoring
techniques to improve monitoring of islet function in our recipients.
Please find enclosed a health history survey and a letter for you to forward
to your primary care physician. Your prompt completion of the survey and
laboratory tests will enable us to properly and efficiently evaluate you as a
potential transplant candidate. Please complete the health history survey and
return to us at the following address:
Islet Transplant Program
University of Tennessee Health Science Center
920 Madison Avenue, Suite 520
Memphis, TN 38103
Currently insurance coverage is doubtful for islet transplants, therefore
patients will be expected to be able to absorb some of the costs for the workup
and the transplant procedure as well as the costs of anti-rejection medications.
Thank you for your interest in the University of Tennessee Islet Transplant
Barbara A. Culbreath, RN, BSN
Coordinator - Islet Transplant Program
As a diabetic individual, a significant portion of your life has been spent
managing your disease as directed by a physician. Now, due to a great deal of
research, another forms of treatment exists for diabetes; those treatments
include PANCREAS and ISLET CELL TRANSPLANTATION. This brochure will provide an
overview of diabetes, the history of pancreas and islet transplantation at our
center, who may be eligible for a pancreas transplant, a description of the
pancreas and islet transplant procedure, and follow-up care.
THE UNIVERSITY OF TENNESSEE TRANSPLANT PROGRAM
In 1998, The University of Tennessee Health Science Center celebrated the 30
year anniversary of its solid organ transplantation program.
The University of Tennessee Organ Transplantation Program was established in
1968. In April 1970, the first kidney transplant was performed and the
University of Tennessee became the 6th program in the nation to transplant
Since then, the program has performed more than 1,800 kidney transplants and
can boast as one of the most successful survival rates in the US. At present,
the first year patient survival rates are above 95% and 5 year rates are over
90%. Kidney transplant success rates are 90% at 1 year and 80% at 5 years
In 1982, The University of Tennessee Health Science Center initiated liver
transplantation and became the third liver transplant program in the US. Since
then, we have performed over 400 liver transplants with survival rates of over
90% at 1 year and 80% at 3 years. During the past 3 years, we have initiated
the split liver transplant program and the living donor liver transplant
program. We have performed over 20 living donor liver transplants making us
one of the most active and successful living donor liver transplant center in
In April 1989, the first simultaneous kidney-pancreas transplant was performed
in the state of Tennessee. In January 1990, The University of Tennessee Health
Science Center became one of the first programs world-wide to perform solitary
pancreas transplantation, offering new hope to diabetic patients.
In 1992, a new technique for transplanting the pancreas using the portal-
enteric drainage was developed by our group. This technique allows for a more
physiological delivery of insulin and drainage of digestive enzymes from the
pancreas. Since then, various transplant centers in the US have adopted our
The University of Tennessee Health Science Center recently became the 10th
program in the US (and 13th program worldwide) to perform more than 200
pancreas transplants. We are currently 1 of the 7 largest pancreas transplant
programs in the country, having performed over 200 simultaneous kidney-pancreas
transplants and over 90 pancreas alone transplants.
Concurrently, we established our islet transplant laboratory in 1994 and
performed our first islet cell transplant in 1995. In September 2001, the
National Institute of Health identified the University of Tennessee Health
Science Center as one of the six Islet Cell Resource centers in the US as a
referral center for human islet cell isolation and clinical transplantation.
FACTS ABOUT DIABETES
Diabetes is a disease resulting from the loss of the bodys ability to produce
or respond to insulin. Insulin is required to control the glucose (sugar)
levels in the blood. Exposure of the body to high glucose levels over several
years or more leads to vascular (blood vessels) disease, coronary heart
disease, kidney disease and damage to the eyes and nerves.
There are 16 million diabetics in the United States (US) today, costing more
than $105 billion annually or about $1 in every $10 spent on health care.
Diabetes afflicts about 6% of the general population in the US, and is
currently the third most common disease and the fourth leading cause of death
by disease in the US. There are 2,200 new cases of diabetes diagnosed every
day in the US. Diabetes accounts for over 160,000 deaths per year, including
3,000 deaths per year in the state of Tennessee. Diabetes is the leading cause
of blindness, kidney failure, non-traumatic limb amputation, impotence in
adults, and ranks among the leading chronic diseases of childhood. In
addition, diabetes can lead to a greater risk of heart attacks, strokes,
infections, and gastrointestinal disturbances.
The loss of glucose control in diabetics is caused by either a lack of insulin
(Type 1 diabetes) or the bodys resistance to the effects of insulin (Type 2
diabetes). Approximately 10 percent of diabetics have Type l diabetes and 90
percent have Type 2.
Type 1 diabetes is caused by the death of the insulin-producing beta cells in
the ISLETS of Langerhans (Clusters of beta cells) in the pancreas. These cells
sense the glucose level in the blood and produce an appropriate amount of
insulin so that the body can use the sugar properly. Type 1 diabetes mainly
occurs in young people, although it may also occur in older adults. The
symptoms usually appear quickly and include hunger, thirst, urination, weight
loss and fatigue.
Type 2 diabetes is caused by the body improperly using insulin that is produced
by the beta cells in the islets of Langerhans in the pancreas. The symptoms
usually develop over a longer period of time and include increased hunger,
thirst and urination, blurred eyesight, fatigue, numbness or tingling in hands
or feet, frequent infections and slow healing cuts or sores.
TREATMENT OPTIONS FOR TYPE 1 DIABETES
Insulin injections and insulin pumps
Insulin injection is the most common therapy for diabetes. The use of an
insulin pump provides the delivery of small amounts of fast-acting insulin 24
hours a day into the body via a small needle or soft tube. Unfortunately, even
the most careful form of insulin therapy cannot copy the precise blood sugar
control that a working pancreas can.
Insulin injections often offer poor sugar control, placing a patient at
significant risk of developing diabetic complications (blindness, kidney
failure, limb amputation, vascular disease, coronary heart disease and cerebral
artery disease) and hypoglycemic episodes or insulin reactions.
Pancreas and islet cell transplantation
Although insulin therapy is life-saving for many diabetic individuals, a number
of diabetic individuals on long-term insulin therapy will eventually develop
some or all of the complications of diabetes previously mentioned.
When considering the probability that a diabetic individual will experience
some of the complications of diabetes, either a pancreas or an islet cell
transplant is an option to seriously consider.
Normally, insulin is produced by beta cells within the Islets of Langerhans
(clusters of beta cells) which reside in a digestive organ called the
pancreas. Healthy islet cells (insulin producing cells) respond to the bodys
blood sugar level from moment to moment, releasing just the right amount of
insulin and preventing complications caused by blood sugar imbalance.
Type 1 diabetic individuals do not have healthy islet cells in their pancreas,
so insulin injections are taken at specific times during the day, in an attempt
to control their blood sugar levels. Unfortunately, due to the many different
variables, diabetic individuals experience erratic blood sugar levels
(many highs and lows). The complications of diabetes generally result from
these erratic blood sugar levels. While an individual with diabetes can often
control their diabetes reasonably well with insulin, there are some patients
where only a normal pancreas with healthy islet cells can effectively control
blood sugars to prevent these complications.
The pancreas also performs a number of other important digestive functions
besides blood sugar control. In a diabetic individual, all of these other
functions are preserved except for the ability to produce insulin from the
islet cells. Therefore, 2 possible ways of treating diabetes are either to
transplant the entire pancreas, or just the islet cells.
PANCREAS OR ISLET CELL TRANSPLANTATION
The average waiting time for a pancreas transplant is 6 to 12 months, due to
the critical shortage of donor organs in the US. During this time, people on
the waiting list continue to perform their normal activities of daily living.
Some may be asked to lose weight or to quit smoking.
Donor organs are obtained from stable, heart-beating individuals who have been
declared brain-dead due to an unfortunate traumatic event. In all cases,
consent has been obtained from the donors family or next of kin for organ
donation. Extensive testing is performed on the donor, not only to document
that the removed organs are functioning normally, but also to ensure that
disease is not transmitted by the transplant process.
Donor organs are matched to the recipients based on blood type, tissue type,
medical needs, and length of time on the waiting list. Once a pancreas is
removed from a stable donor, the team has about 24 hours in which to safely
perform the transplant. During this time, laboratory testing is done between
the donor and potential recipient to determine compatibility.
By the time that the potential recipient is called into the hospital for the
transplant, most of the compatibility testing is completed. Final testing is
performed to verify donor and recipient compatibility, and the patient is
prepared for the surgical procedure. The operation takes approximately 3 to 5
hours, depending on whether the patient is receiving a pancreas only or a
simultaneous kidney-pancreas transplant.
During the transplant procedure, the individuals own pancreas is not removed,
as he or she receives a second pancreas. Patients are usually off of insulin
within a few days, and remain completely insulin free long-term. Patients
spend about 1 to 2 days in the Intensive Care Unit and 7 to 14 days in the
hospital. During this time, they are educated about the change from having
diabetes to becoming a transplant recipient.
Transplant recipients will be on a number of new medications to prevent
rejection and infection. Although the commitment to transplantation is long-
term, most patients experience a straight-forward transition to becoming a
transplant recipient with fewer dietary and activity restrictions and an
enhanced quality of life. Because the trade-off of transplantation is being on
anti-rejection medications rather than on insulin, transplant recipients are
followed long-term in the outpatient clinic by the transplant team.
A pancreas transplant can provide sustained and fully effective insulin
secretion for many years. The benefits of a successful pancreas transplant
include, in most cases, improved quality of life due to decreased dietary
restrictions and normal glucose control with freedom from insulin injections.
The long-term goal of pancreas transplantation is prevention of late
complications of diabetes such as kidney failure and damage to the eyes, nerves
and blood vessels. A pancreas transplant will stabilize, and in a small number
of patients, improve eye disease. Nerve disease also improves in most patients
with a successful pancreas transplant. Additionally, there is evidence that
the transplanted kidney is protected from diabetic damage by a successful
(Figure for pancreas transplant surgery)
Islet transplantation is a minimally invasive procedure that requires a one-
hour operation, a three-inch abdominal incision and a one-day hospital stay.
Islets are obtained from a donor pancreas using a complex isolation and
purification process in which enzymes break down the tissue surrounding the
The islets of Langerhans are embedded within the pancreatic tissue and require
a special, highly technical process to extract them from the pancreas. Islets
are usually transplanted by injecting them into the veins leading to the liver
(the portal vein). The islets migrate to the liver where they reside and
produce insulin. Because pancreatic exocrine tissue is not transplanted during
islet transplantation, complications related to digestive enzyme drainage are
Evaluation Process for Pancreas/ Islet Transplantation
The decision about whether a patient should receive a pancreas or an islet
transplant is complex and requires a full medical evaluation and input from
several medical professionals. The final decision about whether a patient
should receive a whole organ or islet transplant can be made only after a full
medical evaluation is completed.
Potential candidates are assessed in a pre-transplant medical evaluation. This
evaluation begins when a diabetic individual or health care professional calls
the transplant office and requests information regarding either islet or
pancreas transplant. The evaluation process begins by you, the diabetic
individual, answering a questionnaire, which will help the transplant team to
decide if you are eligible to be a potential candidate for transplant.
When a potential candidate is identified, the transplant nurse coordinator
arranges a time for the individual to visit the transplant center. During the
initial visit, detailed information is provided about pancreas and islet
transplantation. Family members or friends are welcome. The individual then
meets with the transplant surgeon who discusses the option of pancreas and
islet cell transplantation. If the surgeon feels that the individual may be
appropriate candidate for transplantation, further visits are arranged for a
thorough medical evaluation.
Potential candidate for transplantation will receive a complete medical
evaluation with a number of tests including: laboratory tests for viruses
(hepatitis, herpes, AIDS, etc.), stomach X-rays, gallbladder ultrasound,
bladder X-rays, EKG (heart rhythm), chest X-rays, dental evaluation, eye exam
(to determine the status of eye disease) and a thallium stress test (heart
treadmill). A pelvic exam with Pap smear and a mammogram are required for
female candidates. Other preliminary tests may include non-invasive vascular
studies to determine the severity of diabetes complications on the blood
vessels to your legs and brain and electromyelogram (EMG) to determine the
severity of diabetes complications to the nerves of your extremities. You may
be requested to undergo a glucose tolerance test or metabolic studies as part
of your pre-transplant evaluation.
The individual may meet with a diabetes specialists, kidney specialist,
pharmacist, financial coordinator, and social worker. If the evaluation
results indicate that the individual would be an appropriate candidate for
either a pancreas or islet cell transplantation, and appropriate financial
arrangements have been made, that individual is then placed on the recipient
waiting list after transplant committee approval.
FINDING OUT IF YOU ARE A PANCREAS OR ISLET TRANSPLANT CANDIDATE
Patients are eligible for Pancreas Transplantation if they have Type 1
diabetes, are between the ages of 16 and 55 and have:
 Autonomic neuropathy (degenerative disease of the nervous system). These
patients usually experience loss of appetite, bloating after eating, nausea,
vomiting, gastric discomfort, constipation or diarrhea and urinary bladder
 Poorly controlled diabetes, despite an appropriate insulin regimen. Such
patients experience wide variations in their blood sugar.
 Repeated hypoglycemic (low blood sugar) episodes requiring emergency
 Repeated bouts of ketoacidosis (a condition where acid builds up in the
Patients are NOT eligible for Pancreas Transplantation if they have any one of
 Presence of active infection.
 Cancer that is not cured or does not have a high chance of cure.
 Alcoholism or other chemical dependency.
 Unstable or advanced heart disease.
 Presence of severe peripheral vascular disease (poor blood flow to arms and
 Not complying with prescribed medication therapy.
 Severe lung disease.
Patients are eligible for Islet Cell Transplantation if they have Type I
diabetes with duration of diabetes > 5 years and between the ages of 18 to 55
years and have:
 Serum C-peptide < 0.48 ng/ml (0.16 nmol/L)
 24-hour urine for creatinine clearance > 50 cc/minute
 24-hour urine for microalbuminuria <300 ug/min
 Difficult to control diabetes resulting in severe hypoglycemia with coma or
 Ability to take medications and comply with an immunosuppression (anti-
 Endocrinologist committed to the procedure
 Men and women (men and women of childbearing years must agree to use
Patients are NOT eligible for Islet Transplantation if they have any one of the
 Uncorrectable heart disease with symptoms of > Stage III New York Heart
 Active infection (including hepatitis B or C, HIV, or tuberculosis)
 Known hypersensitivity to sirolimus or tacrolimus
 Previous kidney, liver or heart transplant
 Pregnancy or unwilling to use birth control; breast-feeding females
 Recent history of substance abuse or current smoker
 Hyperlipidemia uncontrolled by medication while on immunosuppressant regimen
(sirolimus and tacrolimus) for one month pre-transplant
 Untreated diabetic proliferative retinopathy
 Psychogenic factors that effect compliance to medical management
 Panel reactive protein (PRA) > 20%
 Active peptic ulcer disease
 Symptomatic gallstones
 Liver diseases
 Overt microalbuminuria > 300ug/min
WHAT HAPPENS NEXT AFTER I AM LISTED FOR TRANSPLANT?
Waiting for a donor organ and preparing for transplantation
Because we never know when a donor organ will be available, the patient who is
to receive the transplant must be ready on short notice. Patients waiting for a
pancreas or islet transplant must make several telephone numbers available to
the transplant coordinator and wear a pager, so they can be alerted when an
organ is available. All potential recipients must be prepared for immediate
You will be instructed not to drink or eat from the time you are notified of a
pending transplant. Periodically check your finger stick glucose levels and
notify the transplant team should your blood sugar rise over 300 or fall below
You will be admitted to the transplant floor where you will be examined by one
of the transplant surgery residents or surgeons and your blood profiles will be
reviewed to ensure that you are ready for transplantation.
Care after Pancreas Transplant Surgery
Combined pancreas-kidney and solitary pancreas transplant patients are taken to
the Intensive Care Unit (ICU) immediately after surgery. The average stay in
ICU is one to two days. You are then transferred to the transplant unit. You
will receive intravenous fluids since you will not be able to ingest fluids by
mouth for some time. A nasogastric tube is inserted through your nose into your
stomach during surgery to allow the intestines to rest. This tube is usually
removed after three days. During surgery, a catheter is placed into your
bladder to check urinary output. Two small drainage tubes are placed near the
incision during surgery, and are removed before you go home.
Pain medications will be given as needed. The immunosuppressive drugs to help
prevent rejection will be started during the surgery.
Blood sugars are checked frequently to assess the function of your new
pancreas. Bed rest is ordered for approximately 24 hours, after which you may
sit in a chair with assistance. You will have blood work done daily to check
kidney function and pancreas function. Hospital stays usually average about
Care after Islet Cell Transplant Surgery
After infusion of the islet cell, you will be taken to the transplant floor.
Pain medications will be given as needed. The immunosuppressive drugs to help
prevent rejection will be started during the surgery. Your blood sugars are
checked frequently to assess the function of the islet cells. In order to
reduce stress put on the islet cells during the first few days after the
transplant, we may need to give you small doses of insulin. You will also have
blood work done to check your liver function and blood chemistries. You will
be able to eat a regular diet the same day and be sent home the following
What to expect when you return home after pancreas or islet cell transplantation
Once you are home from the hospital, you can set goals for your return to an
active life. Activities such as walking, jogging, hiking, bicycling, tennis,
golf and swimming can help you regain your strength. Renewing intimate
relationships, strengthening old friendships, meeting new people and returning
to work will also help boost your self-confidence and sense of well-being.
It is important after your transplant to have regular checkups with physicians
such as your ophthalmologist, gynecologist, dentist and dermatologist. Be sure
to let them know that you have had a transplant and what medications you are
Wear a bracelet or necklace designating that you are a transplant patient and
give them your transplant physicians emergency phone number. Your dentist
should be aware of your condition so that antibiotics can be used to prevent
possible infection when dental work is done.
Many patients are able to return to work within a few months after the
transplant. For islet cell transplant recipients, you may be able to return to
work the next day after discharge from the hospital. We can keep your employer
informed about when you can return to work, and if there are any limitations on
what you may do.
After your transplant, you will receive low-fat, low-sugar diet guidelines. You
will also need to drink extra fluids to prevent dehydration, especially in the
summer. You will have a tendency to gain weight because of increased appetite
from some of the medications. Excessive weight gain can increase your blood
pressure, so it is important to keep your weight under control.
It is normal to have some emotional ups and downs during this process. However,
it is important to keep a positive outlook. If you find yourself feeling down,
please do not hesitate to talk about it with your nurse and doctors. The social
worker can come to talk to you also. This feeling is a normal reaction for some
Your follow-up visits will be at the Transplant Outpatient Clinic located on
the fourth floor at the 920 Madison Building. Immediately after you are
discharged from the hospital, you will need to go to clinic on Monday,
Wednesday and Friday. As you get stronger, the frequency of your check-up
visits will decrease.
Please arrive between 8 and 8:30 a.m. on the day you are scheduled for clinic.
Physicians, the transplant coordinator and, if appropriate, a dietitian, a
pharmacist, and a social worker will see you during your visit. Bring your
medication list to each visit. You will be notified if a urine sample is needed.
At your follow-up visit you will sign the roster at the desk when you arrive
and wait until you are called. A phlebotomist will draw your blood. You will be
weighed, have your temperature taken and may be asked to provide a urine
sample. Your name will be called when it is your turn to see the physicians.
Generally, you should be finished with the appointment by noon. Make sure you
do not miss an appointment, because it is very important that your medical
condition be carefully monitored.
MEDICATIONS AFTER TRANSPLANT
After your transplant, you will need to take several medications to prevent
rejection as your body thinks that the new pancreas or islet cells are
foreign materials and will want to destroy it. You will likely be on these
medications for the rest of your life or while your pancreas or islet
transplant is functioning well.
These medications called immunosuppressives or anti-rejection medications also
lowered your bodys ability to fight infection, thus you will be on medications
to prevent infections. Patients should be aware of the increased incidence of
infection and seek early treatment from the physician.
While successfully transplanted patients may lead nearly normal lives, they
must have a life-long commitment to taking medications faithfully and having
frequent check-ups. Immunosuppressive drugs must be taken every day, and it is
critical to never miss a dose. Research continues for improvement of anti-
rejection medications and reductions of side effects.
You should never avoid taking your medicine or reduce your dose on your own. To
do so invites a great risk of rejection and losing your transplant. Your
physician will be able to answer questions about specific side effects and
adjust your medications if needed. Side effects of these medications usually
depend on the dose of the drug and can be managed with dosage adjustment or
changing to other medications.
A list of these medicines and some of their side effects is included below.
Trade Name Generic Name Possible Side Effects
Neoral Cyclosporine Flushing, kidney toxicity, hair growth, shaking, sleep
Prograf Tacrolimus flushing, kidney toxicity, shaking, sleep disturbances
Cellcept Mycophenolate Mofetil nausea, diarrhea, abdominal pain, low
Imuran Azathioprine low blood counts
Rapamune Sirolimus diarrhea, high cholesterol
Deltasone Prednisone weight gain, acne, bone loss, cataracts, poor
REJECTION OR OTHER COMPLICATIONS
Rejection is the bodys natural response to the presence of foreign tissue.
Only about 20 percent of patients experience a rejection episode. It is
understandable to be depressed or discouraged at the time of rejection, but you
should realize that rejection episodes are a common part of the transplant
procedure and can be reversed. If rejection occurs after you have gone home,
the physician may want to readmit you to the hospital so you can be watched
more closely during treatment.
Many transplant recipients experience complications besides rejection. Most are
minor, but others may be serious. You will get very close medical supervision
to detect and treat complications as soon as possible. It is vital that you
notify your physician of any signs of infections, such as a cold, cough, sore
throat, fever, chills and skin rashes. Infection can be a serious complication
following a transplant, though most infections are effectively treated with
Remember, rejection, infection and other problems can usually be treated
quickly and effectively if detected early.
Along with receiving a bill for services provided by your transplant team, you
may also receive separate statements for services provided by specialty
physicians involved in your care and departments like Laboratory Medicine and
Radiology, which conduct important testing during your hospital stay and
Hospital costs related to the kidney transplant are usually covered by your
insurance or Medicare. The pancreas portion of the hospitalization is not
always covered by private insurance. In some cases, Medicare does cover it. If
your insurance company has a transplant rider, pancreas transplants are
Currently, islet cell transplantation is not covered by most insurance
agencies; however, alternative financial support for islet transplantation may
be feasible. Our financial counselor will be available to assist you with your
Staff involved in your care
The staff involved in your care includes surgeons, nephrologists (kidney
specialists), endocrinologists (diabetes specialists), a registered nurse who
serves as islet transplant coordinator, transplant pharmacists, clinical nurse
specialists (registered nurses specially trained in transplantation), a social
worker, a dietitian, surgical and medical residents (physicians in training), a
transplant administrator and laboratory personnel.
During your pre-transplant visit to UT Bowld Hospital and the Pre-Transplant
Evaluation Clinic (920 Madison), the transplant team will provide you with
information about your pre-transplant evaluation, the operation, medications,
hospital stay and financial considerations. Our goal is to treat you with
consideration while providing excellent medical care. As a candidate for
pancreas or islet transplantation, you and your family will be involved in all
aspects of your evaluation and treatment process.
HOW TO CONTACT US
If you require any additional information, you can email us at email @ redacted
or call us at 901-448-2630
We are asking that the people getting on the islet cell transplant list have
the resources of $20,000-25,000 for any post-surgical financial obligations.
Our center is making every attempt to get the hospital and doctors to cover
much of the cost for early recipients, but there will be costs not covered. The
medication is costly ($1200 - $1500 per month). We do not know if insurance
companies will cover these costs
for HELP or to subscribe/unsubscribe, contact: HELP@insulin-pumpers.org
send a DONATION http://www.Insulin-Pumpers.org/donate.shtml